Lucid Diagnostics Inc. Selling, General and Administrative Expense
Lucid Diagnostics Inc. (LUCD) reported Selling, General and Administrative Expense of $21.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2023-03-14
- Lucid Diagnostics Inc. selling, general and administrative expense for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- Lucid Diagnostics Inc. selling, general and administrative expense for the quarter ending 2021-09-30 was $8.00K, a 166.67% increase year-over-year.
- Lucid Diagnostics Inc. selling, general and administrative expense for the quarter ending 2021-06-30 was $8.00K.
- Lucid Diagnostics Inc. selling, general and administrative expense for the quarter ending 2021-03-31 was $6.00K.
- Lucid Diagnostics Inc. selling, general and administrative expense for fiscal 2021 was $21.00K, a 200.00% increase from fiscal 2020.
- Lucid Diagnostics Inc. selling, general and administrative expense for fiscal 2020 was $7.00K.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $8.00K derived: sum of 2 quarters · filed 2023-03-14 | $16.00K derived: sum of 3 quarters · filed 2023-03-14 | $21.00K 10-K · filed 2023-03-14 | |
| 2021-09-30 | $8.00K 10-Q · filed 2022-11-14 | $7.50K 10-Q · filed 2021-11-23 | $16.00K derived: sum of 2 quarters · filed 2022-11-14 | $21.00K 10-Q · filed 2022-11-14 | $25.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $8.00K 10-Q · filed 2022-08-15 | $14.00K 10-Q · filed 2022-08-15 | $17.00K derived: sum of 3 quarters · filed 2022-08-15 | $20.00K derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $6.00K 10-Q · filed 2022-05-16 | $9.00K derived: sum of 2 quarters · filed 2022-05-16 | $12.00K derived: sum of 3 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $6.00K derived: sum of 2 quarters · filed 2022-04-06 | $7.00K 10-K · filed 2022-04-06 | ||
| 2020-09-30 | $3.00K 10-Q · filed 2021-11-23 | $4.00K 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |